Ventyx Biosciences Inc. (VTYX)
Ventyx Biosciences Statistics
Share Statistics
Ventyx Biosciences has 71.13M shares outstanding. The number of shares has increased by 0.89% in one year.
Shares Outstanding | 71.13M |
Shares Change (YoY) | 0.89% |
Shares Change (QoQ) | 0.59% |
Owned by Institutions (%) | 77.05% |
Shares Floating | 61.17M |
Failed to Deliver (FTD) Shares | 6.23K |
FTD / Avg. Volume | 0.51% |
Short Selling Information
The latest short interest is 6.68M, so 9.45% of the outstanding shares have been sold short.
Short Interest | 6.68M |
Short % of Shares Out | 9.45% |
Short % of Float | 12.63% |
Short Ratio (days to cover) | 3.5 |
Valuation Ratios
The PE ratio is -1.11 and the forward PE ratio is -0.91. Ventyx Biosciences's PEG ratio is 0.03.
PE Ratio | -1.11 |
Forward PE | -0.91 |
PS Ratio | 0 |
Forward PS | 0.2 |
PB Ratio | 0.59 |
P/FCF Ratio | -1.14 |
PEG Ratio | 0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Ventyx Biosciences.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.97, with a Debt / Equity ratio of 0.04.
Current Ratio | 17.97 |
Quick Ratio | 17.97 |
Debt / Equity | 0.04 |
Debt / EBITDA | -0.07 |
Debt / FCF | -0.08 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $0 |
Profits Per Employee | $-1.71M |
Employee Count | 79 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -79.39% in the last 52 weeks. The beta is 0.75, so Ventyx Biosciences's price volatility has been higher than the market average.
Beta | 0.75 |
52-Week Price Change | -79.39% |
50-Day Moving Average | 1.56 |
200-Day Moving Average | 2.1 |
Relative Strength Index (RSI) | 20.63 |
Average Volume (20 Days) | 1.23M |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | -148.45M |
Net Income | -135.12M |
EBITDA | -148.45M |
EBIT | n/a |
Earnings Per Share (EPS) | -1.97 |
Balance Sheet
The company has 27.26M in cash and 10.79M in debt, giving a net cash position of 16.47M.
Cash & Cash Equivalents | 27.26M |
Total Debt | 10.79M |
Net Cash | 16.47M |
Retained Earnings | -554.31M |
Total Assets | 276.56M |
Working Capital | 216.85M |
Cash Flow
In the last 12 months, operating cash flow was -130.87M and capital expenditures -241K, giving a free cash flow of -131.11M.
Operating Cash Flow | -130.87M |
Capital Expenditures | -241K |
Free Cash Flow | -131.11M |
FCF Per Share | -1.91 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
VTYX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for VTYX is $11, which is 989.1% higher than the current price. The consensus rating is "Buy".
Price Target | $11 |
Price Target Difference | 989.1% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Scores
Altman Z-Score | -1.55 |
Piotroski F-Score | 2 |